Found 7 matching trials
Study to Assess Safety and Ability to Induce Immune Responses of HIV-1 Vaccines M3 and M4 Given Alone or in Combination in HIV-infected Adults
PHASE1This is a double blind, randomized, placebo-controlled, parallel design, st...
Location
University of North Carolina at Chapel Hill
Combination Vaccination and Broadly Neutralising Antibody Therapy in HIV
PHASE2There is no cure for HIV infection. Antiretroviral therapy (ART) is widely ...
Location
Guys and St Thomas' NHS Trust
RV630 - Approach to Control HIV With Immune Enhancement and Vaccination (ACHIEV
PHASE1This is a phase I, randomized, double-blind, placebo-controlled clinical tr...
Location
The Faculty of Medicine, Chulalongkorn University/ King Chulalongkorn Memorial Hospital
A Study to Test Three Experimental HIV Vaccines in Healthy Adults.
PHASE1HIV-CORE 006 is a Phase 1 double-blind placebo-controlled trial, in which t...
Location
Kenya Medical Research Institute Wellcome Trust Programme
A Study to Assess Safety and Immunogenicity of Conserved Mosaic HIV-1 Vaccines
PHASE1The object of the study is to assess the safety profile of candidate vaccin...
Location
Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital
Safety and Immunogenicity of HIV-1 Vaccines C62-M4 or C1C62-M3M4 in Persons With HIV-1 Suppressed on ART
PHASE1This is a double blind, randomized, placebo-controlled, parallel design stu...
Location
University of North Carolina
Evaluation of Safety, Immunogenicity and Efficacy of a Triple Immune Regimen in Adults Initiated on ART During Acute HIV-1
PHASE1The purpose of this study is to evaluate the safety, tolerability, and effi...
Location
University of California, San Diego AntiViral Research Center CRS